- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 190
90 Seconds times $20m series B
The Opt and SKY TV NZ-backed video production platform has collected series B financing from investors including Susquehanna International Group.
Feb 26, 2019Home Depot helps courier $37m to Roadie
Home Depot has taken part in a $37m series C round, which increased the UPS-backed courier service's overall funding to $62m.
Feb 26, 2019RapidAPI interfaces with Microsoft for $25m
Microsoft’s M12 unit has participated in a $25m funding round for RapidAPI, with existing investor Andreessen Horowitz also returning.
Feb 26, 2019Circle Media Labs connects to $20m series B
NetGear and T-Mobile have taken part in the connected device technology startup's $20m series B round, investing alongside Third Venture Capital and Relay Ventures.
Feb 25, 2019Lytics nabs $35m in series C round
Comcast Ventures has taken part in the JMI-led round, which increased the digital marketing platform's overall funding to more than $58m.
Feb 25, 2019Ctrl-Labs senses GV in $28m funding round
The neural interface-tracking technology developer has increased its overall funding to $67m following a GV-led funding round that included Amazon's Alexa Fund.
Feb 25, 2019Ajisen Ramen pays another visit to Yunnex
Fast food retailer Ajisen Ramen reinvested in the smart point-of-sale device provider in a $20m series B-plus round led by Hezhi Investment.
Feb 22, 2019Calypso Biotech dances through series A round
Merck Group and Johnson & Johnson both invested in a $22.6m round for the autoimmune disease drug developer, six years after it was spun off from Merck Serono.
Feb 22, 2019U-M commits $20m to four spinouts
University of Michigan will supply an initial $2.75m in funding to MemryX, Ripple Science, GreenMark Biomedical, and Give and Take, and could invest as much as $20m altogether.
Feb 22, 2019BiomX rides to $32m series B
Johnson & Johnson, Takeda, Chong Kun Dang and Handok were among the participants in a series B round expected to advance acne and IBD drugs into the clinic.
Feb 22, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


